k
keynews.ai
keynews.ai
ToolsThe story, in brief

Anthropic launches Claude Science in push for pharma revenue

Anthropic just shipped Claude Science. Pharma is the new revenue battleground.

Reporting by Financial Times Technology 1 min brief
Paper-cut illustration of amber paths carrying capital toward a small coral research venture between larger buildings.
Capital and the next generation of AI ventures.AI illustration by KeyNews
The KeyNews take

Why it matters

Anthropic is moving beyond consumer/enterprise chat into vertical-specific AI products, targeting high-margin pharma and biotech workflows. This signals a strategic pivot to defensible, domain-locked revenue streams—and a direct counter to OpenAI's enterprise playbook.

The key facts

4 to know

  1. Claude Science product launch targeting pharma/biotech

  2. Use cases: 3D protein structure rendering, drug discovery workflows

  3. Vertical-specific product strategy (distinct from general-purpose Claude)

  4. Pharma revenue diversification play for Anthropic

Go to the source

Financial Times Technologyft.com

Publisher excerpt: New AI product has use cases in rendering 3D protein structures and drug discovery
Read original report
Back to today's editionMore tools news

Keep reading

Related stories

More from Tools
Tools

Anthropic brings Cowork directly inside Claude’s chat interface

Anthropic merges Claude and Claude Cowork into one chat interface, adding Docs and Slides in beta.

SiliconAngleTools

Anthropic Launches Claude Code Projects in Beta: Parallel Cloud Sessions That Keep Running After You Close Your Laptop

Claude Code Projects just turned your laptop into a coordinator. Parallel cloud sessions keep running—and Claude decides what becomes a thread.

MarkTechPostTools

Anthropic merges Claude Chat, Cowork, and more into a single product

Claude just became a workflow engine. Anthropic is merging chat, projects, docs, and slides into one product that decides what you need.

The Decoder